
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
Instead of relying on animals as test subjects, the EPA is planning to use toxicity-based pathways, which involve human cell cultures, to determine the toxicity of various chemicals.
Instead of relying on animals as test subjects, the EPA is planning to use toxicity-based pathways, which involve human cell cultures, to determine the toxicity of various chemicals.





